Bortezomib Injection

Available Composition of

Bortezomib Injection
NameStrengthTherapeutic useView More
Bortezomib Injection

Product Description For Bortezomib Injection

products details and uses

Bortezomib Injection Manufacturer

Bortezomib Injection Manufacturer, we are committed to producing high-quality oncology medicines that meet stringent international standards. Bortezomib Injection is a proteasome inhibitor widely prescribed in the treatment of multiple myeloma and mantle cell lymphoma. It works by interfering with proteasome activity in cancer cells, leading to programmed cell death and slowing the progression of cancer. Manufactured in WHO-GMP-certified facilities, our products are globally recognized for safety, consistency, and reliability. Over the years, we have strengthened our reputation as a leading Bortezomib Injection Manufacturer, Exporter, and Global Supplier serving international healthcare markets.

Overview of Bortezomib Injection

Bortezomib Injection plays a key role in modern oncology treatments. By blocking the action of proteasomes, it prevents cancer cells from breaking down damaged proteins, triggering cell death. This targeted therapy is particularly effective for patients with multiple myeloma and mantle cell lymphoma.

Our expertise as a Bortezomib Injection Manufacturer and Wholesale Supplier ensures that each batch is carefully formulated, tested, and delivered with consistency. Hospitals, oncology centers, and pharmacies rely on our products to provide life-saving care.

Uses of Bortezomib Injection

  • Treatment of multiple myeloma in adult patients.

  • Management of mantle cell lymphoma in patients who cannot undergo conventional therapies.

  • Administered alone or in combination with other cancer medicines to improve results.

  • Enhances patient survival rates and quality of life.

As a recognized Bortezomib Injection Manufacturer, Exporter, and Distributor, we ensure timely access to this essential oncology medication worldwide.

Precautions

Though highly effective, Bortezomib Injection requires certain precautions:

  • It must be administered under the supervision of an oncologist.

  • Not recommended for pregnant or breastfeeding women.

  • Patients with liver, kidney, or heart conditions should use it with caution.

  • Adequate hydration is important during therapy to reduce risks.

  • Patients should disclose all existing medications to avoid interactions.

Being a responsible Bortezomib Injection Manufacturer and Global Supplier, we provide detailed dosage guidelines and safety instructions with every shipment.

Side Effects

Like most chemotherapy medicines, Bortezomib Injection may cause side effects in some patients. These include:

  • Nausea, vomiting, or diarrhea.

  • Fatigue, weakness, or dizziness.

  • Low platelet count, increasing the risk of bleeding.

  • Peripheral neuropathy, causing tingling or numbness in the hands and feet.

  • Increased risk of infections due to immune suppression.

  • Rare but serious complications such as liver or cardiac issues.

Our stringent processes as a Bortezomib Injection Manufacturer and Bulk Supplier ensure quality, safety, and minimized risks through proper formulation and testing.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Bortezomib Injection to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.